BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 53808)

  • 1. A study of the plasma kinin-generating system in children with the minimal lesion, idiopathic nephrotic syndrome.
    Kallen RJ; Lee SK
    Pediatr Res; 1975 Sep; 9(9):705-9. PubMed ID: 53808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [State of the kinin system and level of serum proteinase inhibitors in latent nephritis and the nephrotic syndrome of different etiology].
    Paskhina TS; Poliantseva LR; Krinskaia AV; Belolipetskaia IuG; Nartikova VF
    Vopr Med Khim; 1977; 23(2):241-51. PubMed ID: 70111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma kallikrein during experimentally induced allergic rhinitis: role in kinin formation and contribution to TAME-esterase activity in nasal secretions.
    Baumgarten CR; Nichols RC; Naclerio RM; Lichtenstein LM; Norman PS; Proud D
    J Immunol; 1986 Aug; 137(3):977-82. PubMed ID: 3522740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of vibration on the activity of the plasma kallikrein-kinin system in the rat.
    Gáti T; Budavári I; Szombath D; Losonczy G
    Acta Physiol Acad Sci Hung; 1982; 60(4):213-8. PubMed ID: 6926659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on components of the plasma kallikrein-kinin system in plasma samples from normal individuals and patients with septic shock.
    Aasen AO; Erichsen NS; Gallimore MJ; Amundsen E
    Adv Shock Res; 1980; 4():1-10. PubMed ID: 6172027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Kinin system components, free kinins and proteinase inhibitors in the edematous fluids of nephrotic syndrome patients].
    Paskhina TS; Poliantseva AR; Egorova TP; Krinskaia AV; Nartikova VF
    Vopr Med Khim; 1979; 25(5):588-99. PubMed ID: 91261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prekallikein and kallikrein inhibitor in liver cirrhosis and hepatitis.
    Faciullacci M; Galli P; Monetti MG; Pela I; Del Bianco PL
    Adv Exp Med Biol; 1976; 70(00):201-8. PubMed ID: 1084679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contact activation of human plasma prorenin in vitro.
    Blumberg AL; Sealey JE; Atlas SA; Laragh JH; Dharmgrongartama B; Kaplan AP
    J Lab Clin Med; 1981 Jun; 97(6):771-8. PubMed ID: 7014741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The kallikrein-kinin system in Bartter's syndrome and its response to prostaglandin synthetase inhibition.
    Vinci JM; Gill JR; Bowden RE; Pisano JJ; Izzo JL; Radfar N; Taylor AA; Zusman RM; Bartter FC; Keiser HR
    J Clin Invest; 1978 Jun; 61(6):1671-82. PubMed ID: 96139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Normal plasma arginine esterase and the Hageman factor (factor XII) -prekallikrein-kininogen system in cystic fibrosis.
    Goldsmith GH; Stern RC; Saito H; Ratnoff OD
    J Lab Clin Med; 1977 Jan; 89(1):131-4. PubMed ID: 830773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human plasma alpha 2-macroglobulin. An inhibitor of plasma kallikrein.
    Harpel PC
    J Exp Med; 1970 Aug; 132(2):329-52. PubMed ID: 4101346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating levels of prekallikrein and kallikrein in pregnancy and labor.
    Sayama S; Kashiwagi H; Ogawa T; Terada K; Soma H; Kato M
    Int J Biol Res Pregnancy; 1981; 2(2):90-4. PubMed ID: 6916725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclosporine in idiopathic nephrotic syndrome.
    Ponticelli C
    Immunopharmacol Immunotoxicol; 1993 Aug; 15(4):479-89. PubMed ID: 8227973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Status of the kallikrein-kinin system of the blood in young and middle-aged patients with ischemic heart disease].
    Tsagikian TA; Frolova IA; Paramonova EG
    Vopr Med Khim; 1984; 30(1):104-8. PubMed ID: 6200999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of diet therapy on indices of the activity of the plasma kallikrein-kinin system of young and middle-aged ischemic heart disease patients].
    Samsonov MA; Tsagikian TA; Frolova IA; Meshcheriakova VA; Paramonova EG
    Vopr Pitan; 1984; (5):11-5. PubMed ID: 6083662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Activity of the prekallikrein-kallikrein system and characteristics of its regulation in various allergies].
    Nenasheva NM; Dotsenko VL; Goriachkina LA; Iarovaia GA
    Vopr Med Khim; 1986; 32(5):106-11. PubMed ID: 3640571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Guinea pig plasma kallikrein as a vascular permeability enhancement factor. Its dependence on kinin generation and regulation mechanisms in vivo.
    Imamura T; Yamamoto T; Kambara T
    Am J Pathol; 1984 Apr; 115(1):92-101. PubMed ID: 6424481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fletcher factor deficiency. A diminished rate of Hageman factor activation caused by absence of prekallikrein with abnormalities of coagulation, fibrinolysis, chemotactic activity, and kinin generation.
    Weiss AS; Gallin JI; Kaplan AP
    J Clin Invest; 1974 Feb; 53(2):622-33. PubMed ID: 11344577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunochemical studies of plasma kallikrein.
    Bagdasarian A; Lahiri B; Talamo RC; Wong P; Colman RW
    J Clin Invest; 1974 Dec; 54(6):1444-54. PubMed ID: 4140197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinin and myocardial infarction: effect of Trasylol on the plasma prekallikrein and kallikrein inhibitor.
    Del Bianco PL; Franchi G; Lombardi M; Caleri D; Curradi C; Sicuteri F
    Adv Biosci; 1978 Jul; 17():187-95. PubMed ID: 314912
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 21.